theblood
PrivateLast Round
Seed
May 10, 2024
Total Funding Raised
$1.06M
Company Overview
theblood operates in Healthcare & Life Sciences and is based in Berlin. Its latest recorded funding round was a Pre Seed round in March 2023.
theblood is a FemTech company that provides an at-home test kit for non-invasive menstrual blood analysis to help women monitor their health.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, D2C Brands, Subscription Commerce, Healthcare Analytics
Business Model
B2C
Customer Profile
Subscription SaaS, Data as a Service, Hardware Sales
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
theblood Comparables
Compare theblood with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Diamens | 81% | |
| Hormona | 80% | |
| Qvin | 80% |
For institutional investors. Book with your work email.
theblood Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
theblood Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| RoX Health | Pre Seed |
theblood Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about theblood's valuation, stock price, and market status.
Is theblood a public or private company?
theblood is a private company.
What is the current stock price of theblood?
theblood is a private company, so its shares have no public market price. Caplight tracks theblood's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is theblood worth (valuation)?
Valuation information for theblood is not publicly available.
Can I buy theblood stock?
theblood shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was theblood's last funding round?
theblood's most recent funding round was Seed on May 10, 2024.
Who are the main investors in theblood?
Key investors in theblood include RoX Health.
Will theblood IPO soon?
No public IPO plans have been announced for theblood.
How can I track theblood secondary market activity?
Caplight tracks bids, offers, and trades in theblood's shares on secondary markets.